Quarterly report pursuant to Section 13 or 15(d)

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

v3.22.2.2
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
9 Months Ended
Sep. 30, 2022
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2 - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

Management identified errors made in its historical financial statements related to the valuation and expense of equity-based compensation for management and members of the Company’s board of directors.  The Company accounts for stock-based compensation in accordance with ASC 718. Under the provisions of ASC 718, stock-based compensation cost is estimated at the grant date based on the award’s fair value and is recognized as expense over the requisite service period. At the date of grant, the Company determines the fair value of the stock option award using the Black Scholes option pricing model.

 

The Company made errors in the application of the Black Scholes option valuation model by applying an inappropriate methodology in determining the expected term of granted options. Based on the limited history relating to exercises of options, the Company determined that the expected life of an option grant should be calculated using the simplified method. After recalculating the valuations and reviewing the periodic reported expense for all the options issued as equity-based compensation, the Company concluded that, in aggregate, it had overstated the equity-based compensation. In accordance with SEC Staff Accounting Bulletin No. 99, Materiality, and SEC Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements; the Company evaluated the error quantitatively and qualitatively and has determined that the related impact was not material to any previously presented financial statements. As such the Company corrected the error in the consolidated financial statements for the years ended December 31, 2020 and 2021, and the condensed consolidated financial statements for the three month period ended March 31, 2021, the three month and six month periods ended June 30, 2021, and the three month and nine month period ended September 30, 2021.

 

The impact of the revision on the Company’s previously released financial statements that are reference in this form 10Q are reflected in the following tables. The adjustment below include immaterial footing corrections in certain previously reported balances.  

   

CONSOLIDATED BALANCE SHEET

as of December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Additional paid-in capital

 

$ 87,747,898

 

 

$ (760,319 )

 

$ 86,987,579

 

Accumulated deficit

 

 

(99,063,675 )

 

 

760,319

 

 

 

(98,303,356 )

 

CONSOLIDATED STATEMENT OF OPERATIONS

for the Year Ending December 31, 2020

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

General and Administrative

 

$ 4,820,762

 

 

$ (57,086 )

 

$ 4,763,676

 

Research and Development

 

 

3,754,913

 

 

 

(494,141 )

 

 

3,260,772

 

Total costs and expenses

 

 

8,575,675

 

 

 

(551,227 )

 

 

8,024,448

 

LOSS FROM OPERATIONS

 

 

(8,575,675 )

 

 

551,227

 

 

 

(8,024,448 )

NET LOSS

 

 

(9,105,729 )

 

 

551,227

 

 

 

(8,554,502 )

BASIC AND DILUTED LOSS PER SHARE

 

$ (1.79 )

 

$

 0.11

 

 

$

(1.68 )

 

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

for the Year Ended December 31, 2020

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Balance, December 30, 2019 – Additional Paid in Capital

 

$ 81,614,504

 

 

$ (209,091 )

 

$ 81,405,413

 

Balance, December 30, 2019 – Accumulated Deficit

 

 

(89,957,946 )

 

 

209,091

 

 

 

(89,748,855 )

Employee and director equity-based compensation – Additional Paid in Capital

 

 

2,302,044

 

 

 

(551,227 )

 

 

1,750,817

 

Employee and director equity-based compensation - Total

 

 

2,302,044

 

 

 

(551,227 )

 

 

1,750,817

 

Net loss for the year ended December 31, 2020 – Accumulated Deficit

 

 

(9,105,729 )

 

 

551,227

 

 

 

(8,554,502 )

Net loss for the year ended December 31, 2020 - Total

 

 

(9,105,729 )

 

 

551,227

 

 

 

(8,554,502 )

Balance, December 31, 2020 – Additional Paid in Capital

 

 

87,747,898

 

 

 

(760,319 )

 

 

86,987,579

 

Balance, December 31, 2020 - Accumulated Deficit

 

 

(99,063,675 )

 

 

760,319

 

 

 

(98,303,356 )

 

CONSOLIDATED STATEMENT OF CASH FLOWS

for the Year Ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Net Loss

 

$ (9,105,729 )

 

$ 551,227

 

 

$ (8,554,502 )

Employee and director equity-based compensations

 

 

2,302,044

 

 

 

(551,227 )

 

 

1,750,817

 

CONDENSED CONSOLIDATED BALANCE SHEET

as of March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Additional paid-in capital

 

$ 89,437,765

 

 

$ (837,250 )

 

$ 88,600,515

 

Accumulated deficit

 

 

(101,282,654 )

 

 

837,250

 

 

 

(100,445,404 )

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

for the Three Months Ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

General and Administrative

 

$ 1,436,822

 

 

$ (13,272 )

 

$ 1,423,550

 

Research and Development

 

 

646,752

 

 

 

(63,659 )

 

 

583,093

 

Total costs and expenses

 

 

2,083,574

 

 

 

(76,931 )

 

 

2,006,643

 

LOSS FROM OPERATIONS

 

 

(2,083,574 )

 

 

76,931

 

 

 

(2,006,643 )

NET LOSS

 

 

(2,218,978 )

 

 

76,931

 

 

 

(2,142,047 )

BASIC AND DILUTED LOSS PER SHARE

 

$ (0.43 )

 

$ 0.02

 

 

$ (0.41 )

 

  

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

for the Three Months Ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Balance, December 30, 2020 – Additional Paid in Capital

 

$ 87,747,898

 

 

$ (760,319 )

 

$ 86,987,579

 

Balance, December 30, 2020 – Accumulated Deficit

 

 

(99,063,675 )

 

 

760,319

 

 

 

(98,303,356 )

Issuance of warrants for services – Additional Paid in Capital

 

 

975,024

 

 

 

(76,931 )

 

 

898,093

 

Issuance of warrants for services - Total

 

 

975,024

 

 

 

(76,931 )

 

 

898,093

 

Net loss for the three months ended March 31, 2021 – Accumulated Deficit

 

 

(2,218,978 )

 

 

76,931

 

 

 

(2,142,047

Net loss for the three months ended March 31, 2021 - Total

 

 

(2,218,978 )

 

 

76,931

 

 

 

(2,142,047 )

Balance, March 31, 2021 – Additional Paid in Capital

 

 

89,437,765

 

 

 

(837,250 )

 

 

88,600,515

 

Balance, March 31, 2021 - Accumulated Deficit

 

 

(101,282,654 )

 

 

837,250

 

 

 

(100,445,404 )

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

for the Three Months Ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Net Loss

 

$ (2,218,978 )

 

$ 76,931

 

 

$ (2,142,047 )

Employee and director equity-based compensation expense

 

 

975,024

 

 

 

(76,931 )

 

 

898,093

 

CONDENSED CONSOLIDATED BALANCE SHEET

as of June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Additional paid-in capital

 

$ 110,452,205

 

 

$ (885,726 )

 

$ 109,566,479

 

Accumulated deficit

 

 

(103,128,302 )

 

 

885,725

 

 

 

(102,242,577 )

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

for the Three Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

General and Administrative

 

$ 1,281,488

 

 

$ 972

 

 

$ 1,282,460

 

Research and Development

 

 

467,918

 

 

 

(49,447 )

 

 

418,471

 

Total costs and expenses

 

 

1,749,406

 

 

 

(48,475 )

 

 

1,700,931

 

LOSS FROM OPERATIONS

 

 

(1,749,406 )

 

 

48,475

 

 

 

(1,700,931 )

NET LOSS

 

 

(1,845,648 )

 

 

48,475

 

 

 

(1,797,173 )

BASIC AND DILUTED LOSS PER SHARE

 

$ (0.28 )

 

$ 0.00

 

 

$ (0.28 )

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

for the Six Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

General and Administrative

 

$ 2,718,310

 

 

$ (12,300 )

 

$ 2,706,010

 

Research and Development

 

 

1,114,670

 

 

 

(113,106 )

 

 

1,001,564

 

Total costs and expenses

 

 

3,832,980

 

 

 

(125,406 )

 

 

3,707,574

 

LOSS FROM OPERATIONS

 

 

(3,832,980 )

 

 

125,406

 

 

 

(3,707,574 )

NET LOSS

 

 

(4,064,627 )

 

 

125,406

 

 

 

(3,939,221 )

BASIC AND DILUTED LOSS PER SHARE

 

$ (0.70 )

 

$ 0.03

 

 

$ (0.67 )

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

for the Three Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Balance, March 31, 2021 – Additional Paid in Capital

 

$ 89,437,765

 

 

$ (837,250 )

 

$ 88,600,515

 

Balance, March 31, 2021 – Accumulated Deficit

 

 

(101,282,654 )

 

 

837,250

 

 

 

(100,445,404 )

Issuance of warrants for services – Additional Paid in Capital

 

 

369,965

 

 

 

(48,475 )

 

 

321,490

 

Issuance of warrants for services - Total

 

 

369,965

 

 

 

(48,475 )

 

 

321,490

 

Net loss for the three months ended June 30, 2021 – Accumulated Deficit

 

 

(1,845,648 )

 

 

48,475

 

 

 

(1,797,173 )

Net loss for the three months ended June 30, 2021 - Total

 

 

(1,845,648 )

 

 

48,475

 

 

 

(1,797,173 )

Balance, June 30, 2021 – Additional Paid in Capital

 

 

110,452,205

 

 

 

(885,726 )

 

 

109,566,479

 

Balance, June 30, 2021 - Accumulated Deficit

 

 

(103,128,302 )

 

 

885,725

 

 

 

(102,242,577 )

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

for the Six Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Balance, December 31, 2020 – Additional Paid in Capital

 

$ 87,747,898

 

 

$ (760,319 )

 

$ 86,987,579

 

Balance, December 31, 2020 – Accumulated Deficit

 

 

(99,063,675 )

 

 

760,319

 

 

 

(98,303,356 )

Issuance of warrants for services – Additional Paid in Capital

 

1,344,989

 

 

 

(125,406 )

 

 

1,219,583

 

Issuance of warrants for services - Total

 

 

1,344,989

 

 

 

(125,406 )

 

 

1,219,583

 

Net loss for the six months ended June 30, 2021 – Accumulated Deficit

 

 

(4,064,627 )

 

 

125,406

 

 

 

(3,939,221 )

Net loss for the six months ended June 30, 2021 - Total

 

 

(4,064,627 )

 

 

125,406

 

 

 

(3,939,221 )

Balance, June 30, 2021 – Additional Paid in Capital

 

 

110,452,205

 

 

 

(885,726 )

 

 

109,566,479

 

Balance, June 30, 2021 - Accumulated Deficit

 

 

(103,128,302 )

 

 

885,725

 

 

 

(102,242,577 )

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

for the Six Months Ended June 30, 2021

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Net Loss

 

$ (4,064,627 )

 

$ 125,406

 

 

$ (3,939,221 )

Employee and director equity-based compensation expense

 

 

1,367,389

 

 

 

(125,406 )

 

 

1,241,983

 

CONDENSED CONSOLIDATED BALANCE SHEET

as of September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Additional paid-in capital

 

$ 112,473,855

 

 

$ (918,442 )

 

$ 111,555,413

 

Accumulated deficit

 

 

(104,712,643 )

 

 

918,442

 

 

 

(103,794,201 )

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

for the Three Months Ended September 30, 2021

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

General and Administrative

 

$ 1,263,490

 

 

$ 612

 

 

$

1,264,102

 

Research and Development

 

 

442,340

 

 

 

(33,327 )

 

 

409,013

 

Total costs and expenses

 

 

1,705,830

 

 

 

(32,715 )

 

 

1,673,115

 

LOSS FROM OPERATIONS

 

 

(1,705,830 )

 

 

32,715

 

 

 

(1,673,115 )

NET LOSS

 

 

(1,584,339 )

 

 

32,715

 

 

 

(1,551,624 )

BASIC AND DILUTED LOSS PER SHARE

 

$ (0.17 )

 

$ (0.07 )

 

$ (0.24 )

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

for the Nine Months Ended September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

General and Administrative

 

$ 3,981,801

 

 

$ (11,689 )

 

$ 3,970,112

 

Research and Development

 

 

1,557,010

 

 

 

(146,433 )

 

 

1,410,577

 

Total costs and expenses

 

 

5,538,811

 

 

 

(158,122 )

 

 

5,380,689

 

LOSS FROM OPERATIONS

 

 

(5,538,811 )

 

 

158,122

 

 

 

(5,380,689 )

NET LOSS

 

 

(5,648,968 )

 

 

158,123

 

 

 

(5,490,845 )

BASIC AND DILUTED LOSS PER SHARE

 

$ (0.81 )

 

$ (0.13 )

 

$ (0.94 )

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

for the Three Months Ended September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Balance, June 30, 2021 – Additional Paid in Capital

 

$ 110,452,205

 

 

$ (885,726 )

 

$ 109,566,479

 

Balance, June 30, 2021 – Accumulated Deficit

 

 

(103,128,302 )

 

 

885,725

 

 

 

(102,242,577 )

Issuance of warrants for services – Additional Paid in Capital

 

 

256,920

 

 

 

(32,714 )

 

 

224,206

 

Issuance of warrants for services - Total

 

 

256,920

 

 

 

(32,714 )

 

 

224,206

 

Net loss for the three months ended September 30, 2021 – Accumulated Deficit

 

 

(1,584,339 )

 

 

32,715

 

 

 

(1,551,624 )

Net loss for the three months ended September 30, 2021 - Total

 

 

(1,584,339 )

 

 

32,715

 

 

 

(1,551,624 )

Balance, September 30, 2021 – Additional Paid in Capital

 

 

112,473,855

 

 

 

(918,442 )

 

 

111,555,413

 

Balance, September 30, 2021 - Accumulated Deficit

 

 

(104,712,643 )

 

 

918,442

 

 

 

(103,794,201 )

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

for the Nine Months Ended September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Balance, December 30, 2020 – Additional Paid in Capital

 

$ 87,747,898

 

 

$ (760,319 )

 

$ 86,987,579

 

Balance, December 30, 2020 – Accumulated Deficit

 

 

(99,063,675 )

 

 

760,319

 

 

 

(98,303,356 )

Issuance of warrants for services – Additional Paid in Capital

 

 

1,601,909

 

 

 

(158,121 )

 

 

1,443,788

 

Issuance of warrants for services - Total

 

 

1,601,909

 

 

 

(158,121 )

 

 

1,443,788

 

Net loss for the nine months ended September 30, 2021 – Accumulated Deficit

 

 

(5,648,968 )

 

 

158,123

 

 

 

(5,490,845 )

Net loss for the nine months ended September 30, 2021 - Total

 

 

(5,648,968 )

 

 

158,123

 

 

 

(5,490,845 )

Balance, September 30, 2021 – Additional Paid in Capital

 

 

112,473,855

 

 

 

(918,442 )

 

 

111,555,413

 

Balance, September 30, 2021 -

Accumulated Deficit

 

 

(104,712,643 )

 

 

918,442

 

 

 

(103,794,201 )

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

for the Nine Months Ended of September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Net Loss

 

$ (5,648,968 )

 

$ 158,123

 

 

$ (5,490,845 )

Employee and director equity-based compensation expense

 

 

1,624,309

 

 

 

(158,121 )

 

 

1,466,188

 

CONSOLIDATED BALANCE SHEET

as of December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Additional paid-in capital

 

$ 114,259,830

 

 

$ (1,167,805 )

 

$ 113,092,025

 

Accumulated deficit

 

$ (108,227,041 )

 

$ 1,167,805

 

 

$ (107,059,236 )

 

CONSOLIDATED STATEMENT OF OPERATIONS

for the Year Ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

General and Administrative

 

$ 6,932,921

 

 

$ (238,302)

 

 

$ 6,694,619

 

Research and Development

 

 

2,119,684

 

 

 

(169,184)

 

 

 

1,950,500

 

Total costs and expenses

 

 

9,052,605

 

 

 

(407,486)

 

 

 

8,645,119

 

LOSS FROM OPERATIONS

 

 

(9,052,605 )

 

 

407,486

 

 

 

(8,645,119 )

NET LOSS

 

 

(9,163,366 )

 

 

407,485

 

 

 

(8,755,881 )

BASIC AND DILUTED LOSS PER SHARE

 

$ (1.20 )

 

$ 0.05

 

 

$ (1.15 )

 

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

for the Year Ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Balance, December 30, 2020 – Additional Paid in Capital

 

$ 87,747,898

 

 

$ (760,319 )

 

$ 86,987,579

 

Balance, December 30, 2020 – Accumulated Deficit

 

 

(99,063,675 )

 

 

760,319

 

 

 

(98,303,356 )

Employee and director equity-based compensation – Additional Paid in Capital

 

 

3,377,512

 

 

 

(407,485 )

 

 

2,970,027

 

Employee and director equity-based compensation - Total

 

 

3,377,512

 

 

 

(407,485 )

 

 

2,970,027

 

Net loss for the year ended December 31, 2021 – Accumulated Deficit

 

 

(9,163,366 )

 

 

407,485

 

 

 

(8,755,881 )

Net loss for the year ended December 31, 2021 - Total

 

 

(9,163,366 )

 

 

407,485

 

 

 

(8,755,881 )

Balance, December 31, 2021 – Additional Paid in Capital

 

 

114,259,830

 

 

 

(1,167,805 )

 

 

113,092,025

 

Balance, December 31, 2021 - Accumulated Deficit

 

 

(108,227,041 )

 

 

1,167,805

 

 

 

(107,059,236 )

 

CONSOLIDATED STATEMENT OF CASH FLOWS

for the Year Ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

 

 

 

 

 

 

 

Reported

 

 

Adjustment

 

 

As Revised

 

Net Loss

 

$ (9,163,366 )

 

$ 407,485

 

 

$ (8,755,881 )

Employee and director equity-based compensation

 

 

3,377,512

 

 

 

(407,485 )

 

 

2,970,027